| 引用本文: |
江雨洁,张湘卓,陈悦,张书萌,于子璇,刘佳,陈伶利,李杰.早发冠心病血瘀证DNA羟甲基化相关差异基因研究[J].湖南中医药大学学报,2022,42(4):651-658[点击复制] |
|
| |
|
|
| 本文已被：浏览 1668次 下载 484次 |
| 早发冠心病血瘀证DNA羟甲基化相关差异基因研究 |
| 江雨洁,张湘卓,陈悦,张书萌,于子璇,刘佳,陈伶利,李杰 |
| (湖南中医药大学, 湖南 长沙 410208) |
| 摘要: |
| 目的 探讨早发冠心病（premature coronary heart disease, PCHD）血瘀证DNA羟甲基化相关差异基因表达，以期寻找PCHD血瘀证诊断和治疗的新靶点。方法 病例来自湖南中医药大学第二附属医院PCHD患者，分为PCHD血瘀证组（A组）和PCHD非血瘀证组（B组），各6例，采用DNA羟甲基化免疫共沉淀芯片技术分析两组的相关羟甲基化差异基因表达情况，并对其进行聚类分析、KEGG通路富集分析及GO功能富集分析。结果 A组与B组相比，高CpG密度启动子差异羟甲基化基因数目343个，低CpG密度启动子差异羟甲基化基因数目144个，通路富集分析得出PCHD血瘀证羟甲基化差异基因主要与细胞周期、心肌能量代谢、炎症、内皮损伤有关，GO功能富集分析得出PCHD血瘀证生物学功能多与细胞发育和分化、蛋白酶活性、细胞内结构等有关。A组的CDKN1B、HDAC2、MDM2羟甲基化表达程度均较高。结论 PCHD血瘀证差异基因羟甲基化表达程度较高，这些差异基因主要与转录调控心肌细胞周期有关，可能影响心肌细胞周期阻滞、凋亡、衰老等，导致疾病的发生发展，为PCHD血瘀证诊断和治疗提供一定的参考。 |
| 关键词: 早发冠心病 血瘀证 DNA羟甲基化 差异基因 表观遗传学 |
| DOI：10.3969/j.issn.1674－070X.2022.04.022 |
| 投稿时间：2021-05-10 |
| 基金项目:国家自然科学基金项目（81874375）；湖南省自然科学基金项目（2020JJ4464）；湖南省中医药科研计划重点项目（2021024）；湖南省教育厅科学研究重点项目（21A0231)；湖南中医药大学校级科研重点项目（2020XJJJ002）；湖南中医药大学研究生科研创新课题项目（2020CX59）。 |
|
| Study on the DNA hydroxymethylation related difference genes in premature coronary heart disease with blood stasis syndrome |
| JIANG Yujie,ZHANG Xiangzhuo,CHEN Yue,ZHANG Shumeng,YU Zixuan,LIU Jia,CHEN Lingli,LI Jie |
| (Hunan University of Chinese Medicine, Changsha, Hunan 410208, China) |
| Abstract: |
| Objective To explore the differential expression of DNA hydroxylmethylation related genes in premature coronary heart disease (PCHD) with blood stasis syndrome, in order to find a new target for diagnosis and treatment of PCHD with blood stasis syndrome. Methods The patients were from PCHD patients in The Second Affiliated Hospital of Hunan University of Chinese Medicine. They were divided into PCHD with blood stasis syndrome group (group A) and PCHD with non-blood stasis syndrome group (group B), with 6 patients in each group. DNA hydroxymethylated immunoprecipitation chip technique was used to analyze the differential gene expression of related hydroxymethylation between the two groups. Cluster analysis, KEGG pathway enrichment analysis and GO function enrichment analysis were performed. Results Compared with group B, group A had 343 differential hydroxymethylation genes with high CpG density promoter and 144 differential hydroxymethylation genes with low CpG density promoter. Pathway enrichment analysis showed that the differential genes of hydroxymethylation in PCHD with blood stasis syndrome were mainly related to cell cycle, myocardial energy metabolism, inflammation and endothelial injury. Go function enrichment analysis showed that the biological functions of PCHD with blood stasis syndrome were mostly related to cell development and differentiation, protease activity, intracellular structure and so on. The degree of hydroxymethylation of CDKN1B, HDAC2, MDM2 in group A was higher than that in group B. Conclusion The expression degree of hydroxymethylation of differential genes in PCHD with blood stasis syndrome is higher. These differential genes are mainly related to transcriptional regulation of myocardial cell cycle, which may affect cardiomyocyte cycle arrest, apoptosis, senescence and so on, leading to the occurrence and development of the disease, which provides a reference for the diagnosis and treatment of PCHD with blood stasis syndrome. |
| Key words: premature coronary heart disease blood stasis syndrome DNA hydroxymethylation differential gene epigenetics |
|
二维码（扫一下试试看！） |
|
|
|
|
